<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33977447</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>2296</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Methods in Screening Antiviral Drugs Against Enterovirus 71.</ArticleTitle><Pagination><StartPage>167</StartPage><EndPage>184</EndPage><MedlinePgn>167-184</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-1358-0_9</ELocationID><Abstract><AbstractText>Enteroviruses 71 (EV71) is a single-stranded, neurotrophic RNA virus responsible for the numerous outbreaks of hand, foot, and mouth disease (HFMD) in the Asia-Pacific regions. HFMD primarily affects children to cause range of infection, from mild symptoms to acute flaccid paralysis, and hemorrhage. Despite increased incidence of EV71 epidemics globally and research against EV71 becoming prioritized, no antiviral agent against EV71 has yet been licensed and approved worldwide. In this chapter, detailed EV71 antiviral screening techniques are described, including plaque assay which determines viral titers through the use of a semisolid overlay, carboxymethyl cellulose to allow even viral spread and infection across the host cellular monolayers as well as a crystal violet, a distinct counterstain to visualize circular regions of infectious zones-plaques. qRT-PCR is used to quantify the viral genomic RNA in the infected samples and MTS cell viability assay to quantify the cell viability after infection or toxicity of the compound on the cells. Furthermore, various antiviral inhibition assays including prophylactic, post infection, and virucidal assays are demonstrated for estimation of the antiviral activity of potential antiviral drugs against EV71. These methods can be effectively utilized in virology laboratories for effective high-throughput screening of antiviral molecules against EV71 that can assist in the future development of antiviral drugs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bajaber</LastName><ForeName>Nadia Abubakar Omar Abubakar</ForeName><Initials>NAOA</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Kuala Lumpur, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramanathan</LastName><ForeName>Babu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Kuala Lumpur, Selangor, Malaysia. babur@sunway.edu.my.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057166" MajorTopicYN="N">High-Throughput Screening Assays</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral assays</Keyword><Keyword MajorTopicYN="N">Cytopathic effect</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">High-throughput assay</Keyword><Keyword MajorTopicYN="N">MTS assay</Keyword><Keyword MajorTopicYN="N">Plaque assay</Keyword><Keyword MajorTopicYN="N">RNA copy number</Keyword><Keyword MajorTopicYN="N">RT-PCR</Keyword><Keyword MajorTopicYN="N">Virus quantification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>12</Day><Hour>7</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33977447</ArticleId><ArticleId IdType="doi">10.1007/978-1-0716-1358-0_9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim C, Kang H, Kim D, Song J, Choi M, Kang M (2016) Antiviral activity of micafungin against enterovirus 71. Virol J 13:99</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0557-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourianfar H, Grollo L (2015) Development of antiviral agents toward enterovirus 71 infection. J Microbiol Immunol Infect 48:1&#x2013;8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2013.11.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua K, Kasri A (2011) Hand foot and mouth disease due to enterovirus 71 in Malaysia. Virol Sin 26:221&#x2013;228</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-011-3195-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourianfar H, Javadi A, Grollo L (2012) A colorimetric-based accurate method for the determination of enterovirus 71 titer. Indian J Virol 23:303&#x2013;310</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-012-0105-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper P (1962) The plaque assay of animal viruses. Adv Virus Res 8:319&#x2013;378</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(08)60689-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Juarez D, Long K, Aguilar P, Kochel T, Halsey E (2013) Assessment of plaque assay methods for alphaviruses. J Virol Methods 187:185&#x2013;189</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.09.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis BD, Dulbecco R, Eisen HN, Ginsberg H, Wood WB (1972) Nature of viruses in: microbiology. Harper &amp; Row, New York, pp 1044&#x2013;1053</Citation></Reference><Reference><Citation>Baer A, Kehn-Hall K (2014) Viral concentration determination through plaque assays: using traditional and novel overlay systems. J Vis Exp: e52065. doi: https://doi.org/10.3791/52065</Citation></Reference><Reference><Citation>Yin Y, Xu Y, Ou Z, Su L, Xia H (2014) A simple and highly repeatable viral plaque assay for enterovirus 71. J Basic Microbiol 55:538&#x2013;541</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jobm.201400330</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren P, Zou G, Bailly B, Xu S, Zeng M, Chen X, Shen L, Zhang Y, Guillon P, Arenzana-Seisdedos F, Buchy P, Li J, von Itzstein M, Li Q, Altmeyer R (2014) The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection&#x2014;suramin inhibits EV71 infection in vitro and in vivo. Emerg Microbes Infect 3:1&#x2013;9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.60</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C, Chan Y, Sim K, Tan E, Poh C (2012) Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1. PLoS One 7:e34589</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034589</ArticleId></ArticleIdList></Reference><Reference><Citation>Deepak SA, Kottapalli KR, Rakwal R, Oros G, Rangappa KS, Iwahashi H, Masuo Y, Agrawal GK (2007) Real-time PCR: revolutionizing detection and expression analysis of genes. Curr Genomics 8:234&#x2013;251</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920207781386960</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo Y, Wan R, Zhang Q (2012) Application of reverse transcription-PCR and real-time PCR in Nanotoxicity research. Methods Mol Biol 926:99&#x2013;112</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-002-1_7</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>